Burada yer alan hibir ifade tbbi tavsiye, tehis veya tedavi nerisi nitelii tamaz
McKesey J, Tovar-Garza A, Pandya AG
The increasing prevalence of obesity and type 2 diabetes mellitus (T2DM) presents a major global health challenge, as many existing therapies lack adequate efficacy and safety. As a triple-action agonist, retatrutide enhances satiety, suppresses hunger and boosts energy expenditure, potentially providing superior benefits for blood sugar control and weight loss compared to other incretin-based therapies
Clinicians, AASM, and the IRLSSG are working hard to change the narrative and protect patients from the harms of these drugs
eLife 5 , e18722 (2016) Emsley, P
In clinical trials, Semaglutide has been shown to cause greater weight loss than other medications